ArticleAmerican journal of translational research2025
Effect of radiofrequency catheter ablation on cardiac function and quality of life in atrial fibrillation patients.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- NovelBiomedicines · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo conduct a comprehensive analysis of the therapeutic efficacy of radiofrequency ablation (RFA) in patients with atrial fibrillation (AF), focusing on the effect on cardiac function and quality of life.
methodsNinety-eight AF patients treated at the Second Affiliated Hospital of Xi'an Jiaotong University were included in this study. Of these, 45 patients were assigned to the control group, which only underwent mitral valve replacement surgery, while 53 patients in the observation group that underwent RFA in addition to mitral valve replacement. Comparative analyses were performed between the two groups in terms of left atrial (LA) structure, LA function, segmental LA function, negative emotions, postoperative complications, treatment satisfaction, quality of life, sleep quality, and insomnia rate.
resultsAfter treatment, the observation group showed significantly greater improvement in the left-right diameter, conduit volume, and LA total emptying fraction (LATEF) compared to the control group. Additionally, the observation group exhibited significantly lower strain (S) values in the middle and basal segments of the posterior wall, as well as in the average strain values for each segment. The S change rate, systolic peak strain rate (SRs), early diastolic peak strain rate (SRe), and late diastolic peak strain rate (SRa) in the middle and basal segments of the posterior wall in the observation group were markedly lower than the average values across all segments (all P<0.05). Furthermore, negative emotions were significantly alleviated and quality of life was markedly enhanced in the observation group compared to the control group (P<0.05). There was no significant difference in the incidence of postoperative complications between the two groups (P>0.05). The insomnia rate of the observation group was markedly lower compared with the control group, and the overall patient satisfaction was significantly higher (P<0.05).
conclusionsRFA significantly improves the left atrial function and reduces compensatory mechanisms in AF patients. It also contributes to the alleviation of negative emotions and enhances quality of life, with a favorable safety profile.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.